[Methylethyl(silatran-1-ylmethyl)sulfonium iodide--an inhibitor of the development of experimental atherosclerosis of the aorta].
Rasulov
M M
MM
Kuznetsov
I G
IG
Sorokin
M S
MS
Voronkov
M G
MG
D000818:Animals; D001018:Aortic Diseases / Q000097:blood / Q000517:prevention & control*; D001161:Arteriosclerosis / Q000097:blood / Q000517:prevention & control*; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004357:Drug Synergism; D006868:Hydrolysis; D008055:Lipids / Q000097:blood; D011817:Rabbits; D012459:Salicylates / Q000494:pharmacology; D012825:Silicon / Q000494:pharmacology*; D013452:Sulfonium Compounds
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D002951:Citrates; D008055:Lipids; D012459:Salicylates; D013452:Sulfonium Compounds; D019343:Citric Acid; C058763:methylethyl(silatrane-1-ylmethyl)sulfonium; D012825:Silicon
Metilétil(silatran-1-ilmetil)sul'foniĭ ĭodid--ingibitor razvitiia éksperimentalnogo ateroskleroza aorty.